source
- Catalent to divest UK site; Rottendorf, Evonik announce manufacturing buildsPlus, news about RoslinCT, Novo Nordisk and more. 🇬🇧 Catalent to sell UK site to Codis: The CDMO is set to take Catalent’s oral solid dose factory in Nottingham, with ...Endpoints · 21d ago↗ source
- HHS plan to speed drug research won’t remove ‘self-inflicted’ delaysU.S. clinical trials continue to lose ground to China, but is Operation Trialblazer enough to help America catch up?BioPharma Dive · 21d ago↗ source
- AstraZeneca, Ionis drug fails big heart disease study in major setbackEplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and boosted the outlook of rival drugs from Alnylam and BridgeBio Pharma.BioPharma Dive